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Vacuolar protein sorting 34 (Vps34) complexes, the
class III PtdIns3 kinase, specifically phosphorylate
the D3 position of PtdIns to produce PtdIns3P.
Vps34 is involved in the control of multiple key intra-
cellular membrane trafficking pathways including
endocytic sortingandautophagy. Inmammaliancells,
Vps34 interacts with Beclin 1, an ortholog of Atg6
in yeast, to regulate the production of PtdIns3P and
autophagy. We show that Vps34 is phosphorylated
on Thr159 by Cdk1, which negatively regulates its
interaction with Beclin 1 during mitosis. Cdk5/p25,
a neuronal Cdk shown to play a role in Alzheimer’s
disease, can also phosphorylate Thr159 of Vps34.
Phosphorylation of Vps34 on Thr159 inhibits its inter-
actionwithBeclin 1.Wepropose thatphosphorylation
of Thr159 in Vps34 is a key regulatory mechanism
that controls the class III PtdIns3 kinase activity in
cell-cycle progression, development, and human
diseases including neurodegeneration and cancers.
INTRODUCTION
Vacuolar protein sorting 34 (Vps34), a class III PtdIns3 kinase
(phosphatidylinositol 3-kinase), was first identified as a regulator
of vacuolar hydrolase sorting in yeast (Herman and Emr, 1990).
Vps34 specifically phosphorylates theD-3 position on the inositol
ring of phosphatidylinositol (PtdIns) to produce PtdIns3P (Schu
et al., 1993). In yeast, Vps34 is present in two complexes that
are involved in the regulating autophagy (complex I) and vacuolar
protein sorting (complex II) (Kihara et al., 2001b). In mammalian
cells, Vps34 is present in multiple protein complexes that include
regulatory proteins Beclin 1 and p150 as well as one or more of
the following proteins: Atg14L, UVRAG, and a negative regulator
Rubicon (Itakura et al., 2008;Matsunaga et al., 2009; Zhong et al.,500 Molecular Cell 38, 500–511, May 28, 2010 ª2010 Elsevier Inc.2009). Dynamic regulation of Vps34 complexes may provide an
important regulatory mechanism to control multiple vesicular
trafficking pathways. Although the class III PI3 kinase has been
recognized to play an important role in regulatingmany important
intracellular and extracellular signaling events in mediating
membrane trafficking including endocytosis and autophagy, we
still know very little about the molecular mechanisms that
regulate the interaction of Vps34 with its partners.
Cyclin-dependent kinases (Cdks) are critical regulators of
multiple cellular processes that include cell-cycle progression,
development, and intracellular signaling in response to external
stimuli. Their activity is tightly regulated and restricted to specific
stages of the cell cycle. Cdk5, which is closely related to Cdk1
but not a part of the core cell-cycle machinery, normally func-
tions during the development of nervous systems by regulating
neuronal migration and neuritic outgrowth as well as neurotrans-
mitter signaling in the mature nervous system (Dhavan and Tsai,
2001). Cdk5 was found to be abnormally activated by p25,
a proteolytic product of p35, the normal partner of Cdk5, to
aberrantly hyperphosphorylate tau to contribute to the formation
of neurofibrillary tangles, an important pathological event in
Alzheimer’s disease (AD) (Patrick et al., 1999).
In this study, we examined the mechanism that regulates
the Vps34 complexes by Cdks. We show that Thr159 of Vps34
can be phosphorylated by Cdk1 and Cdk5, which inhibits its
interaction with Beclin 1. We show that phosphorylation of
Thr159 in Vps34 occurs specifically in mitotic cells and in p25
transgenic (Tg) mice, a model of AD (Cruz et al., 2006). Our
results demonstrate that the phosphorylation of Thr159 in
Vps34 is an important regulatory event in the membrane traf-
ficking in mammalian cells and may contribute to neurodegener-
ation in human diseases such as AD.RESULTS
Regulation of Autophagy and PtdIns3P in Mitotic Cells
Eskelinen et al. reported that the number of autophagosomes
was reduced in nocodazole-arrested mitotic cells and proposed
Figure 1. The Levels of Autophagy and
PtdIns3P Are Decreased during Mitosis
(A) Asynchronously growing H4 cells stably ex-
pressing LC3-GFP were counterstained with
Hoechst dye to visualize nuclei and fixed with 4%
paraformaldehyde. The Z series were acquired at
603 magnification on a wide-field microscope,
and deconvolved. Maximum projection images
are shown. The levels of autophagy were assessed
in interphase and mitotic cells by quantifying the
translocation of LC3-GFP from diffuse cytosolic to
punctate autophagosomal location from the
picturesandexpressedasa ratioof LC3-GFP inten-
sity in autophagosomal (spot signal) versus cyto-
solic (diffused signal) location per cell. The data
represent an analysis of 13 mitotic and 28 inter-
phase cells from two independent experiments.
Error bars indicate standard deviation. *p = 0.04.
(B) Asynchronously growing H4 cells stably
expressing FYVE-dsRed were counterstained
with DAPI to visualize nuclei and fixed with 4%
paraformaldehyde. The Z series were acquired
on a wide-field microscope at 603 magnification
and deconvolved. Maximum projection images
are shown. The levels of PtdIns3P were assessed
in interphase versus mitotic cells by quantifying
the amount of FYVE-dsRed from the pictures
and expressed as number of FYVE-dsRed spots
per cell. The data represent an analysis of 14
mitotic and 20 interphase cells from two indepen-
dent experiments. Error bars indicate standard
deviation. ***p = 0.0007.
Molecular Cell
Inhibition of Vps34 by Cdk Mediated Phosphorylationthat autophagymight be inhibited duringmitosis (Eskelinen et al.,
2002). To determine if the levels of autophagy are indeed
reduced during mitosis in an asynchronously proliferating cell
population, we used human glioblastoma H4 cells expressing
LC3-GFP, a marker of autophagosomes (Kabeya et al., 2000).
We first observed the numbers and intensity of LC3-GFP dots
in the mitotic versus interphase cells using fluorescent micros-
copy. We found that the cells in the interphase contained
significantly more LC3-GFP-positive autophagosomes than the
mitotic cells (Figure 1A). We quantified the intensity of LC3-
GFP present on the autophagosomes versus the total intensity
of LC3-GFP expression in the mitotic and interphase cells under
normal asynchronously proliferating state using fluorescent
microscopy with Z stack analysis. Our data indicate that the
fraction of LC3-GFP localized to autophagosomes is signifi-
cantly decreased in the mitotic as compared to the interphase
cells (p = 0.04 in two-tailed equal variance Student’s t test)
(Figure 1A). From these results, we conclude that autophagy is
indeed significantly reduced in mitotic cells.
To study the mechanism by which autophagy is inhibited
in mitotic cells, we measured the changes in the levels of phos-Molecular Cell 38, 500–5phatidylinositol-3-phosphate (PtdIns3P),
a key lipid messenger required for au-
tophagy (Kametaka et al., 1998) during
cell cycle using H4 cells expressing a
PtdIns3P-binding reporter protein FYVEfusedwith a fluorescentmarker protein dsRed (H4-FYVE-dsRed)
(Gaullier et al., 1998; Gillooly et al., 2000; Kutateladze et al.,
1999). Analysis of asynchronously proliferating H4-FYVE-dsRed
cells using 3D fluorescent microscopy showed a significant
reduction in the FYVE-dsRed dots in mitotic cells as compared
to the interphase cells (p = 0.0007), suggesting a significant
reduction in the levels of PtdIns3P in mitotic cells (Figure 1B).
Taken together, our results indicate that a reduction in autopha-
gic activity in mitotic cells is associated with a reduction in the
levels of PtdIns3P and suggest that the activity of Vps34
complex, the class III PtdIns3 kinase responsible for the produc-
tion of PtdIns3P, might be reduced in mitotic cells.
Vps34 Is a Substrate of Cdk1
Since the levels of PtdIns3P are reduced specifically in mitotic
cells, we hypothesize that the mitotic kinase Cdk1 might
negatively regulate the activity of the class III PtdIns3 kinase
Vps34 complex. Based on an analysis of the amino acid
sequence of Vps34 using the Scansite (http://scansite.mit.edu/),
Thr159 of Vps34 is a strongly predicted phosphorylation site for
Cdk1. To examine if Cdk1 can directly phosphorylate Vps34,11, May 28, 2010 ª2010 Elsevier Inc. 501
Figure 2. Vps34 Is Phosphorylated by Cdk1
(A) Equal amounts of purified Flag-tagged Vps34 WT or T159A protein
complexes were incubated with active Cdk1/cyclin B1 complex in an in vitro
phosphorylation assay with [g-32P]-ATP in the absence or presence of
alsterpaullon (0.1 mM), and phosphorylation of Vps34 protein was detected
by autoradiography after proteins were resolved on SDS-PAGE. The ratios
of 32P signal versus anti-Flag signal were indicated below.
(B) Equal amounts of purified Flag-tagged Vps34 WT complexes were incu-
bated with active Cdk1/cyclin B1 complex in an in vitro phosphorylation assay
with ATP in the absence or presence of roscovitine (1 mM). The samples were
either mock treated or phosphatase treated as indicated. Phosphorylation of
Vps34 protein was detected with anti-pThr159 Vps34 antibody by western
blotting.
(C) Flag-Vps34 was incubated with mitotic extract after two rounds of Cdk1
depletion using anti-Cdk1, or mock-depleted asynchronous or mitotic 293T
extracts using a control antibody. The amount of residual Cdk1 was measured
by western blotting. Phosphorylation of Vps34 was measured by western
blotting with anti-pThr159 Vps34 antibody.
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502 Molecular Cell 38, 500–511, May 28, 2010 ª2010 Elsevier Inc.we incubated immunoprecipitated Vps34 protein with or with-
out recombinant Cdk1/cyclin B complex in the presence of
[g-32P]-ATP. The levels of Vps34 phosphorylation were signifi-
cantly increased when incubated with recombinant Cdk1/cyclin
B complex but reduced in the presence of alsterpaullon,
a specific inhibitor of Cdk1 (Figure 2A). Consistent with the phos-
phorylation of T159 by Cdk1, the phosphorylation of T159A
mutant in the same reaction was significantly lower than that
of WT.
To determine if Thr159 of Vps34 is phosphorylated by Cdk1,
we generated an antibody that specifically recognizes phos-
phorylated Thr159 region (anti-pT159-Vps34). As shown in
Figure 2B, recognition of Vps34 by this antibodywas significantly
enhanced following incubation with Cdk1/cyclin B complex but
was inhibited in the presence of roscovitine. Consistent with
a high specificity of the anti-pThr159 Vps34 antibody used, the
anti-pT159 of Vps34 signal was significantly reduced after phos-
phatase treatment. To further confirm that Cdk1 is the specific
kinase for Vps34 phosphorylation, we immunodepleted Cdk1
from the mitotic cell lysate. The levels of Vps34 phosphorylation
in vitro were higher after incubation with mitotic cell lysates than
that of asynchronized lysate. Furthermore, the phosphorylation
of T159 Vps34 in mitotic lysates was significantly reduced after
immunodepletion of Cdk1 compared to that of mock-depleted
mitotic lysate (Figure 2C). From these results, we conclude that
Cdk1/cyclin B can phosphorylate Thr159 of Vps34.
Vps34 Is Phosphorylated at T159 in Mitotic Cells
Since Cdk1/cyclin B is specifically activated during the mitotic
phase, we hypothesize that Thr159 of Vps34 may be phosphor-
ylated specifically during mitosis. Exposure of proliferating cells
to a microtubule destabilizing agent, nocodazole, induces
mitotic arrest. 293T, H4, and HeLa cells were treated with noco-
dazole (200 ng/ml) to synchronize these cell lines in the mitotic
phase and the cell lysates were analyzed by western blotting
using anti-pT159-Vps34 antibody. As shown in Figure 3A, phos-
phorylation of Thr159 in Vps34 was increased in a time-depen-
dent manner upon nocodazole treatment. Treatment with Cdk1
inhibitors roscovitine (10 mM) or alsterpaullon (1 mM) dramatically
reduced nocodazole-induced Thr159 phosphorylation on Vps34
(Figure 3B). Moreover, treatment of phosphatase after synchro-
nizing H4 and HeLa cells in mitosis also resulted in decreased
phosphorylation of Vps34 as recognized by anti-pT159-Vps34
antibody (Figure 3C).
To determine whether the increase of Vps34 Thr159 phos-
phorylation was caused by the stress elicited by interference
with microtubule stability or a normal cell-cycle event associated
withmitosis, wemonitored the levels of Vps34 Thr159 phosphor-
ylation in synchronized H4 cells after releasing serum-starved
cells from the G0/G1 block by serum addition. While the levels
of total Vps34 protein remained relatively constant during cell
cycle, the maximum level of Vps34 Thr159 phosphorylation
was detected at 36 hr post-serum addition, which coincided
with the time when the levels of cyclin B reached its peak
(Figure 3D). To further confirm this result, we analyzed the
levels of Vps34 Thr159 phosphorylation in HeLa cells synchro-
nized using double thymidine block procedure. As shown
in Figure 3E, the levels of phosphorylated Vps34 were
Figure 3. Vps34 Is Phosphorylated in the
Mitotic Phase
(A) Treatment of proliferating 293T, H4, and HeLa
cells with nocodazole for indicated amount of
times led to a gradual increase of Vps34 Thr159
phosphorylation as detected by western blotting
using anti-pT159 antibody. Anti-tubulin was used
as a loading control.
(B) HeLa cells were arrested in mitosis using
200 ng/ml nocodazole for 16 hr. Two different
Cdk1 inhibitors, alsterpaullone (1 mM) and roscovi-
tine (10 mM), reduced nocodazole-induced
Vps34 Thr159 phosphorylation. Phosphorylation
of Vps34 was detected by western blotting using
anti-pT159 antibody.
(C) H4 and HeLa cells were treated with nocoda-
zole for 16 hr, and the lysates were analyzed by
western blotting with anti-pT159 antibody with or
without l phosphatase treatment as indicated.
(D and E) HeLa cells were harvested after serum
addition to induce synchronous cell cycle re-
entering after 3 days of serum deprivation (D) or
release from double thymidine block (E). The total
lysates were analyzed at the indicated time points
by western blotting with anti-cyclin B1 and anti-
pT159 antibody.
(F and G) Asynchronously proliferating HeLa
cells were fixed by paraformaldehyde and immu-
nostained with anti-Vps34 (F) or affinity-purified
anti-pThr159 Vps34 (G) antibodies and DAPI.
Vps34, phosphorylated Vps34, DAPI, and merged
images were shown in each stage of the cell cycle.
These images were magnified from Figures S1A
and S1B. Scale bar, 10 mm.
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in the mitotic phase. Taken together, we conclude that the
phosphorylation of Vps34 at Thr159 is a normal mitotic phase-
associated event.
We next examined the expression and subcellular localization
of Thr159-phosphorylated Vps34 in asynchronously proliferating
HeLa cells during interphase and mitotic phase by immunofluo-
rescencemicroscopy. In human cells, Vps34was localized in the
perinuclear area in the interphase (Kihara et al., 2001a). In the
mitotic cells, Vps34 was evenly distributed in the cells after
nuclear envelope breakdown (Figure 3F and see Figure S1A
available online). On the other hand, the signal for p-Thr159
Vps34 was largely absent in nonmitotic cells but significantlyMolecular Cell 38, 500–increased in the cells during early mitotic
phase (prophase, metaphase, and
anaphase) and dramatically reduced in
the late mitotic phase (telophase/cytoki-
nesis) (Figure 3G and Figure S1B). This
result is consistent with the western blot-
ting analysis as shown in Figure 3E: the
levels of Thr159-phosphorylated Vps34
were significantly decreased at 14 hr after
the release when cyclin B expression was
also decreased. These data indicate that
in HeLa cells, Vps34 is phosphorylated onThr159 in the early mitotic phase, but dephosphorylated in the
late mitotic phase.
Cdk5 Can Also Phosphorylate Vps34
Although Cdk5, a member of the Cdk family, does not play a
role in the regulation of cell cycle as Cdk1, Cdk5 has also been
reported to phosphorylate certain substrates of Cdk1 (Smith
and Tsai, 2002). To test if Cdk5 can phosphorylate Vps34, we
incubated immunoprecipitated Vps34 protein with or without re-
combinant Cdk5/p25 complex in the presence of [g-32P]-ATP.
As shown in Figure 4A, the levels of 32P-labeled Vps34 were
increased after the incubation with recombinant Cdk5/p25
complex.511, May 28, 2010 ª2010 Elsevier Inc. 503
Figure 4. Vps34 Is Phosphorylated by Cdk5/
p25
(A) Vps34 was immunoprecipitated using anti-Flag
antibody from 293T cells transfected with Flag-
Vps34 vector and incubated in the absence or
with different amounts of Cdk5/p25 complex and
[g-32P] ATP. The mixtures were resolved with 8%
SDS/PAGE and subjected to autoradiography.
Relative ratios of the 32P signals divided by the
amount of protein are indicated.
(B) A schematic representation of phosphorylation
sites on Vps34. The upper side shows phosphory-
lation sites detected without incubation with
Cdk5/p25. The under side shows two additional
phosphorylation sites detected only after incuba-
tion with Cdk5/p25.
(C) Lysates from H4 cells expressing Cdk5/p25
were either untreated or treated with lPP prior to
western blotting with anti-pThr159 Vps34 and total
Vps34 antibodies.
(D) 293T cells were transfected with indicated
expression constructs of Vps34 with or without
that of Cdk5/p25. The immunoprecipitants with
anti-Flag antibody were analyzed by western
blotting using anti-pThr159 Vps34 and anti-Flag
antibodies.
(E) H4 cells were transfected with Cdk5/p25
vectors with or without 10 mM roscovitine (Ros).
After 20 hr, the whole-cell lysates were analyzed
by western blotting using anti-pThr159 Vps34
and total Vps34 antibodies.
(F) Western blotting analysis of CK-p25 Tg mouse
forebrain lysates after induced for 2 or 5 weeks
(Tg-On) or not induced (control) (Tg-Off) using
anti-pT159 Vps34, total Vps34, anti-p35, and
anti-tubulin (as a loading control).
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p25, we immunoprecipitated Vps34 from cells cotransfected
with Cdk5/p25 or vector controls and analyzed the sites of
phosphorylation by matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF MS) analysis.
Phosphorylated Thr163, Ser164, Ser244, Ser282, and Ser455
of Vps34 were detected without cotransfection with Cdk5/p25.
However, two additional amino acids in Vps34, Thr159 and
Thr668, were found to be phosphorylated only after cotransfec-
tion with Cdk5/p25 (Figure 4B).
We next tested the ability of anti-pT159-Vps34 antibody to
detect Vps34 phosphorylated by Cdk5/p25. Lysates of H4 cells
transfectedwith Cdk5/p25 expression vector were prepared and
either left untreated or treated with lambda protein phosphatase
(lPP) prior to immunoblotting. Anti-pThr159-Vps34 antibody de-
tected phosphorylated Thr159 Vps34 only in the lysates of cells
expressing Cdk5/p25. The signal was completely removed by
the phosphatase treatment. In contrast, the addition of phospha-
tase had no effect on the total levels of Vps34 (Figure 4C).
We further confirmed the phosphorylation of Thr159 by Cdk5/
p25 using Vps34 mutants. We analyzed the immunoprecipitates
isolated with anti-Flag antibody from 293T cells transfected with
vectors expressing Flag-taggedwild-type (WT), T159A, or T668A504 Molecular Cell 38, 500–511, May 28, 2010 ª2010 Elsevier Inc.mutant forms of Vps34 in the presence or absence of Cdk5/p25
by immunoblotting using anti-pT159-Vps34 and Flag antibodies.
Although the expression levels of total Vps34 were not appre-
ciably different, anti-pT159-Vps34 antibody detected a stronger
signal in cells expressing Cdk5/p25 than those without Cdk5/
p25 (lanes 1 and 2, Figure 4D). Mutation of Thr159 to Ala
(T159A) resulted in a complete loss of recognition by anti-
pT159-Vps34 antibody. On the other hand, T688A mutation in
Vps34 did not change its recognition by anti-pT159-Vps34 anti-
body or the levels of phosphorylation in the presence of cdk5/
p25 (lanes 3 and 4, Figure 4D). These results demonstrate that
Cdk5/p25 can phosphorylate Thr159 of Vps34.
To further examine if Cdk5/p25 can mediate the phosphoryla-
tion of endogenous Vps34 in cells, we analyzed the lysates of H4
cells transfected with Cdk5/p25 or vectors control with or
without the treatment with roscovitine using anti-pT159-Vps34
antibody. As expected, Thr159-phosphorylated Vps34 was de-
tected in Cdk5/p25-expressing cells, and the phosphorylation
was attenuated by roscovitine (Figure 4E).
To confirm the phosphorylation of Vps34 in vivo, we used
anti-pT159-Vps34 antibody to examine the phosphorylation
status of Thr159 site in CK-p25 Tg mouse brains after inducing
p25 expression which activates endogenous Cdk5 (Cruz et al.,
Molecular Cell
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phosphorylated Vps34 was observed after 2 and 5 weeks p25
induction, which was when the earliest biochemical changes
could be observed in this line of Tg mice after inducing p25
expression (Cruz et al., 2003). Taken together, we conclude
that Thr159 Vps34 can be phosphorylated by Cdk5/p25 in vitro
and in vivo.
Since Vps34 is known to be positively regulated by p150
(Panaretou et al., 1997; Yan et al., 2009), we tested whether
the expression of p150 had any effect on Thr159 phosphoryla-
tion of Vps34. We found that overexpression of p150 did not
lead to T159 phosphorylation of Vps34, nor did it have any effect
on T159 phosphorylation by Cdk5/p25 (Figure S2). Thus, it is
most likely that Cdks directly target and phosphorylate Vps34.
Thr159 Phosphorylation Negatively Regulates the
Interaction of Vps34 with Beclin 1
The activity of type III PI3 kinase is determined by the interaction
of Vps34 with its regulatory subunits, including Beclin 1. There-
fore, we evaluated the effect of T159 phosphorylation on Beclin
1/Vps34 complex formation. To identify the Vps34 domain that
binds to Beclin 1, we coexpressed individual Vps34 domains
(Figure S3A) with domains of Beclin 1 in 293T cells. Consistent
with previous reports (Furuya et al., 2005; Liang et al., 2006),
the C2 domain of Vps34, where T159 is localized, bound to Be-
clin 1 (Figure S3B). Conversely, the coiled-coil domain (CCD) and
the ECD of Beclin 1 were required for binding of Vps34
(Figure S3C). To determine whether Cdk5/p25 can influence
the Beclin 1/Vps34 complex, we cotransfected 293T cells with
Flag-Vps34 and GFP-Beclin 1 in the presence or absence of
Cdk5/p25 expression. GFP-tagged Beclin 1 could be coimmu-
noprecipitated with Flag-tagged Vps34 by anti-Flag antibody
in the absence of Cdk5/p25. When p25 and Cdk5 were
coexpressed, coimmunoprecipitation of GFP-Beclin 1 with
Flag-Vps34 was drastically reduced (Figure 5A). However, the
interaction of Vps34 and Beclin 1 was partially rescued in the
Cdk5/p25-expressing cells in the presence of roscovitine
(Figure 5A), suggesting that the kinase activity of Cdk5/p25
was necessary for the disruption of the Beclin 1/Vps34 complex.
Similarly, HA-tagged Vps34 could be coimmunoprecipitated
with Flag-tagged Beclin 1 by anti-Flag antibody in the absence
of Cdk5/p25 expression. This interaction was significantly
reduced in Cdk5/p25-expressing cells (Figure 5B).
To confirm that endogenous Beclin 1/Vps34 complex is
regulated by Cdk5/p25, we transfected p25 expression vector
into H4 cells and immunoprecipitated Vps34 complex using
anti-Beclin 1 antibody. We found that the endogenous Vps34
was coimmunoprecipitated with endogenous Beclin 1 in the
absence of p25 expression, but this interaction was disrupted
by p25 expression (Figure 5C). To examine if the formation of
Vps34 /Beclin 1 complex is also disrupted in the mitotic phase
due to the Cdk1/cyclin B activity, we synchronized HeLa cells
with 16 hr nocodazole treatment and immunoprecipitated with
Beclin 1 antibody. As expected, this interaction was significantly
reduced in mitotic as compared with asynchronous cells
(Figure 5D). Taken together, we conclude that the interaction of
Beclin 1/Vps34 is disrupted in the presence of active Cdk5/p25
or Cdk1.To examine if the phosphorylation of Thr159 and/or Thr668
in Vps34 by Cdk5/p25 is responsible for the observed reduction
of Beclin 1/Vps34 interaction, we compared the interaction of
T159A, T668A, or WT Vps34 with Beclin 1 with or without
Cdk5/p25. As shown in Figure 5E, coimmunoprecipitation of
Flag-tagged WT or T688A Vps34 with GFP-tagged Beclin 1
was inhibited by the expression of Cdk5/p25, whereas that of
T159A Vps34 with Beclin 1 was insensitive to cdk5/p25 expres-
sion. Similarly, coimmunoprecipitation of Flag-tagged Beclin 1
with HA-tagged WT or T688A Vps34 was reduced by Cdk5/
p25 expression, while the interaction of flagged-Beclin 1 with
T159A Vps34 was not affected by Cdk5/p25 expression
(Figure 5F). Interestingly, in both experiments the phosphomu-
tant Vps34 (T159A) showed an increased interaction with Beclin
1 as compared with WT Vps34 (Figures 5E and 5F). Taken
together, these data provide strong evidence that Cdk5/p25
phosphorylation of Thr159 in the C2 domain responsible for
interacting with Beclin 1 reduces the interaction of Vps34 with
Beclin 1.
Thr159 Phosphorylation Negatively Regulates
the PtdIns3 Kinase Activity of Vps34 and Autophagy
Since the experiments described above demonstrated an
important role of Thr159 phosphorylation in regulating the inter-
action of Vps34 with Beclin 1, we wished to further evaluate the
functional significance of this finding. We examined the levels of
FYVE-dsRed dots in control vector or p25 expressing H4-FYVE-
dsRed cells. Under nutrient-rich condition, H4-FYVE-dsRed
cells showed no significant difference in the FYVE-dsRed dots
with or without p25 expression. However, under starvation
condition, known to induce autophagy, the FYVE-dsRed dot
formation in p25-transfected H4-FYVE-dsRed cells was signifi-
cantly lower than in control vector-transfected H4-FYVE-dsRed
cells, which was recovered by roscovitine treatment (Figure 6A).
Thus, the expression of p25 reduces the production of PtdIns3P
under starvation condition by phosphorylating Thr159 of Vps34.
To further test if Thr159 phosphorylation of Vps34 might
reduce its lipid kinase activity in converting PtdIns to PtdIns3P,
we transfected 293T cells with vectors expressing Flag-tagged
WT Vps34 and GFP-Beclin 1 in the presence or absence of
Cdk5/p25 expression. We immunoprecipitated Vps34 protein
with anti-Flag antibody and incubated it with purified bovine
phosphatidylinositol in the presence of [g-32P]-ATP. Extracted
phospholipid products were separated by thin-layer chromatog-
raphy. Consistent with a lower level of FYVE-dsRed dots in
p25-expressing cells, Vps34 immunoprecipitated from cells
expressing Cdk5 and p25 demonstrated a much lower level of
PtdIns3 kinase activity in converting PtdIns to PtdIns3P in vitro
(Figure 6B). As a control, treatment with wortmannin, a general
PtdIns3 kinase inhibitor, completely inhibited the PtdIns3 kinase
activity (Figure 6B).
As discussed above, the phosphomutant Vps34 (T159A) has
shown an increased interaction with Beclin 1 as compared with
that of WT Vps34 (Figures 5D and 5E). To evaluate whether
this phosphomutant Vps34 T159A has increased PtdIns3 lipid
kinase activity, we evaluated the class III PtdIns3 kinase activity
in immunoprecipitated Vps34/Beclin 1 complexes from 293T
cells expressing Flag-tagged WT or phosphomutant T159AMolecular Cell 38, 500–511, May 28, 2010 ª2010 Elsevier Inc. 505
Figure 5. Cdk5/p25 Disrupts Beclin 1/Vps34 Complex
(A) 293T cells were transfected with Flag-Vps34 and GFP-Beclin 1 with or without Cdk5/p25 expression vectors. Flag-Vps34 was immunoprecipitated with anti-
Flag antibody from the lysates. The immunoprecipitates were blotted with anti-GFP antibody and subsequently probed with anti-Flag, p35, and Cdk5 antibodies.
(B) HA-Vps34 and Flag-Beclin 1 with or without Cdk5/p25 expression vectors were transfected into 293T cells. The protein complexes were immunoprecipitated
using anti-Flag antibody and analyzed by western blotting using anti-HA antibody.
(C) H4 cells were transfected with or without p25 expression vector. Beclin 1 was immunoprecipitated with anti-Beclin 1 antibody from the lysates. The
immunoprecipitates were analyzed by western blotting using anti-Vps34 antibody.
(D) HeLa cells were synchronized in mitotic phase with nocodazole. Beclin 1 was immunoprecipitated with anti-Beclin 1 antibody from lysates. The immunopre-
cipitates were analyzed by western blotting using anti-Vps34 and pThr159 Vps34 antibodies.
(E) 293T cells were transfected with Flag-tagged Vps34 WT, mutant T159A, T668A, and GFP-Beclin 1 with or without Cdk5/p25 expression vectors.
Flag-Vps34 was immunoprecipitated with anti-Flag antibody from the lysates. The immunocomplexes were analyzed by western blotting using anti-GFP and
Flag antibodies.
(F) 293T cells were transfected with Flag-tagged Beclin 1 with HA tagged Vps34 WT, mutant T159A, and T668A with or without Cdk5/p25 expression
vectors. Flag-Beclin 1 was immunoprecipitated with anti-Flag antibody from the lysates. The immunocomplexes were analyzed using anti-HA and Flag
antibodies.
Molecular Cell
Inhibition of Vps34 by Cdk Mediated PhosphorylationVps34 and GFP-Beclin 1. Interestingly, we found that the com-
plex with phosphomutant T159A Vps34 exhibited dramatically
higher class III PtdIns3 kinase activity than that of WT Vps34
(Figure 6C).
To determine the effect of Vps34 T159A mutant/Beclin 1
complex in vivo, we transfected H4-FYVE-dsRed cells with WT506 Molecular Cell 38, 500–511, May 28, 2010 ª2010 Elsevier Inc.or Vps34 T159A mutant, with or without Beclin 1. Consistent
with the lipid kinase assay data, FYVE-dsRed dot formation
was significantly increased only when the cells were cotran-
fected with Vps34 T159A mutant and Beclin 1 (Figure 6D).
To further determine whether autophagy is regulated con-
sistently with the lipid kinase activity of Vps34 by Cdk5 and
Figure 6. Phosphorylation of Vps34 Negatively Regulates the Class III PI3 Kinase Activity
(A) H4 cells stably expressing FYVE-dsRed were transfected with p25 expression vector. FYVE-dsRed H4 cells were stimulated for 2 hr with HBSS as starvation
condition or with roscovitine in HBSS to inhibit Cdk5 activity. The cells were fixed with 3.7% formaldehyde and used for quantifying the intensity of FYVE-dsRed
dots with MetaMorph. Statistical analysis was performed by Student’s t test. Error bars indicate standard error. *p < 0.05.
(B) 293T cells were transfected with vector control (lane 1), with Flag-Vps34 and GFP-Beclin 1 (lane 2 and 4), with Flag-Vps34, GFP-Beclin 1 and Cdk5/p25 (lane
3). The whole-cell lysates were used for immunoprecipitation using anti-Flag antibody followed by an assay for Vps34 lipid kinase activity. Wortmannin (10 mM)
was added prior to PtdIns3P kinase assay (lane 4) as a positive control.
(C) 293T cells were transfected with vector control (lane 1), with Flag-taggedWT Vps34 andGFP-Beclin 1 (lane 2), with Flag-tagged phosphomutant T159A Vps34
and GFP-Beclin 1 (lane 3). Flag-tagged Vps34 was immunoprecipitated with anti-Flag antibody and followed by an assay for Vps34 lipid kinase activity. Relative
ratios of the 32P signal divided by the amount of protein are indicated for (B) and (C).
(D) H4 cells stably expressing FYVE-dsRed were transfected with WT or phosphomutant T159A Vps34, with or without Beclin 1. Cells were fixed and the number
of FYVE dots were quantified. Error bars indicate standard error. *p < 0.01.
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LC3-GFP. Under nutrient-rich condition in which a minimal
level of autophagy occurs, transfection of p25 did not affect
the basal levels of autophagy, which was very low already.
However, p25 significantly reduced the level of starvation-
induced autophagy, consistent with the decrease of PI3P forma-
tion by p25 (Figure 7A). We also tested the effect of Vps34 T159A
mutant, which is more active than theWT Vps34. Under nutrient-
rich condition, the level of autophagy was increased in the cells
transfected with Vps34 T159A mutant. The difference of autoph-
agy level between them was diminished in starved cells, sug-
gesting that Vps34 T159A mutant partially mimics starvation
condition (Figure 7B).
Finally, since we found that T668 can also be phosphorylated
by Cdk5 (Figure 4B), we examined the requirement of T668 for
the lipid kinase activity of Vps34. As shown in Figure 7C,
T668A, T668D, or T668E Vps34 were all inactive in the in vitro
lipid kinase assay. To determine the relative contribution of
T159 and T668 phosphorylation by Cdk5 to inhibiting the lipid
kinase activity, we tested the activity of T159A Vps34 protein
immunoprecipitated from Cdk5/p25-expressing cells. The lipid
kinase activity of T159A Vps34 mutant was also inhibited by
Cdk5/p25 (Figure 7D); furthermore, overexpression of p25 in
H4 cells resulted in inhibition of autophagy even in the presence
of T159A Vps34 overexpression (Figure 7E). Thus, Cdks may
have two mechanisms to negatively regulate Vps34: phosphory-
lation of T159, which interferes with its binding to Beclin 1, and
phosphorylation of T668, a residue in the catalytic domain that
is required for the lipid kinase activity.
DISCUSSION
Our study demonstrates amechanism that regulates the interac-
tion of Vps34with its key partner Beclin 1 by Cdks. It provides the
first example of dynamic regulation of intracellular PtdIns3P
production in mammalian cells through phosphorylation of the
class III PI3 kinase. Since Cdk1 is a key mitotic kinase, while
Cdk5 is involved in neural development by controlling axonal
outgrowth and neuronal migration as well as neurodegeneration
(Dhavan and Tsai, 2001) and abnormal regulation of Cdks has
also been implicated in tumorigenesis (Malumbres and
Barbacid, 2009), our study has implications for understanding
of the regulation of PtdIns3P during cell-cycle progression,
development, and in major human diseases including neurode-
generation and cancers.
Regulation of Vps34 and Beclin 1 Interaction
Our study provides a mechanism that regulates PtdIns3P under
conditions that are not nutritionally limiting but when Cdks are
activated. Since phosphorylation of Vps34 at Thr159 of the C2
domain by Cdk5 and Cdc2/Cdk1 inhibits its interaction with
Beclin 1, a critical regulator subunit of the class III PI3 kinase
complex, this mechanism may be utilized by the members of
Cdk family to directly regulate the production and/or distribution
of PtdIns3P under different physiological and pathological
conditions. For example, phosphorylation of Vps34 in cancer
cells by abnormally activated Cdks may provide a mechanism
to lead to inhibition of class III PI3 kinase activity and autophagy,508 Molecular Cell 38, 500–511, May 28, 2010 ª2010 Elsevier Inc.which may in turn contribute to genomic instability (Karantza-
Wadsworth et al., 2007). Since the stability of individual compo-
nents in the Vps34 complex is highly dependent upon each other
(Itakura et al., 2008), phosphorylation of T159may accelerate the
degradation of Vps34 complex.
In the S. cerevisiae, the ATG6/VPS30 gene product is required
for both autophagy and sorting of the vacuole resident hydrolase
carboxypeptidase Y through the Vps pathway (Kametaka et al.,
1998). In mammalian cells, in addition to regulating autophagy
and endosomal trafficking, Beclin 1 is known as a haploinsuffi-
cient tumor suppressor (Qu et al., 2003; Yue et al., 2003). Beclin
1 contains a BH3-only domain (Maiuri et al., 2007; Oberstein
et al., 2007) and interacts with Bcl-2 (Pattingre et al., 2005). Since
increased interaction of Beclin 1 with Bcl-2 has been shown to
negatively regulate autophagy by competing for binding with
Vps34, phosphorylation of Thr159 on Vps34 may release Beclin
1, which in turn may increase its interaction with other cellular
partners and positively regulate additional Beclin 1-mediated
cellular processes.
Inhibition of Vps34 Kinase Activity by Cdk5 Mediated
T668 Phosphorylation
From a mass spectrometric analysis, we have identified T668,
a residue in the catalytic domain of Vps34, as a Cdk5 phosphor-
ylation site. Any mutations we introduced in this site totally
abolished Vps34 lipid kinase activity (Figure 7C). Although we
do not yet have an antibody that can monitor the phosphoryla-
tion status of T668, this result suggests that T668 is required
for the lipid kinase activity. This result also suggests that Cdk5
may have twomechanisms to negatively regulate Vps34 activity:
phosphorylation of T668 to inhibit its lipid kinase activity and
phosphorylation of T159 to interfere with its binding with Beclin
1. Since interfering with the Vps34 and Beclin 1 interaction
may disrupt the Vps34 complex and in turn accelerate the
degradation of individual components, inhibitory effect of T159
phosphorylation may be long lasting. On the other hand, phos-
phorylation of T668 may lead to a transient inhibition of Vps34
lipid kinase activity, which may be rapidly reactivated with an
appropriate phosphatase. These possibilities may be directly
examined by experiments in the future.
Changes in the Distributions of PtdIns3P in Mitosis
Inhibition of Vps34 activity has been shown to lead to multiple
defects in vesicular trafficking such as membrane receptor
degradation andmultivesicular body formation. Phosphorylation
of Vps34 by Cdks, however, may lead to a redistribution of
Vps34 kinase activity by modulating its interaction with Beclin
1 and perhaps with other partners as well, rather than a total inhi-
bition of Vps34 lipid kinase activity. Since suppression of Beclin 1
expression has been shown to lead to inhibition of autophagy
(Liang et al., 1999; Zeng et al., 2006) and PtdIns3P is known to
be important for autophagy signaling, inhibition of Vps34 activity
may provide an important mechanism to regulate autophagy
during mitosis after nuclear membrane breakdown. Phosphory-
lation of Vps34 during mitosis may function to selectively reduce
the input to the autophagosome compartment during mitosis
without affecting early endosomal trafficking. On the other
hand, selective inhibition of membrane trafficking to the
Figure 7. Phosphorylation of Vps34 Results in the Inhibition of Autophagy
(A) H4 cells expressing LC3-GFP were transfected with p25 expression vector. Twenty-two hours after the transfection, starvation was induced by culturing in
HBSS only. The cells were fixed after 1 and 2 hr of starvation with 3.7% formaldehyde and the area of LC3-GFP dots was quantified using MetaMorph. Error bars
indicate standard deviation. *p < 0.05.
(B) H4 cells expressing LC3-GFP were transfected withWT or T159A Vps34 mutant. Twenty-two hours after the transfection, starvation was induced by culturing
in HBSS only. The cells were fixed after 1 and 2 hr of starvation with 3.7% formaldehyde and analyzed as in (A). Error bars indicate standard deviation. *p < 0.05.
(C) 293T cells were transfected with different expression vectors of WT and T668A, T668D, and T668E mutants in different combination and lipid kinase assays
were conducted as in Figure 6.
(D) 293T cells were transfected with indicated expression vectors, and lipid kinase assays were conducted as in Figure 6. Relative ratios of the 32P signal divided
by the amount of protein as measured by the densitometry are indicated.
(E) H4 cells expressing LC3-GFP were transfected with WT or T159A mutant Vps34 expression vector with or without p25 expression vector. Twenty-two hours
after the transfection, starvation was induced by culturing in HBSS only for 2 hr. The cells were fixed with 4% paraformaldehyde, and the intensity of LC3-GFP
dots was quantified using MetaMorph. Error bars indicate standard error. ***p < 0.01.
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Golgi compartment, which undergoes a complete fragmentation
during mitosis (for review, see Nelson, 2000). Although Beclin 1
may not be the partner for Vps34 in regulation of the vesicular
trafficking (Zeng et al., 2006), phosphorylation of Vps34 may
affect its interaction with additional partner(s) mediating endo-
some to lysosome transport, which remains to be explored in
future studies.
Cdks, Autophagy, and Neuronal Cell Death
Our study demonstrates a mechanism by which two members
of the Cdk family of protein kinases, Cdk1 and Cdk5, nega-
tively regulate the production of PtdIns3P, which may in turn
negatively regulate autophagy. In yeast, Pho85p, a member
of yeast Cdk family and a regulator of phosphate metabolism
and glycogen synthase, has been shown to be a negative
regulator of autophagy (Wang et al., 2001). Increased autopha-
gic activity, observed in WT cells entering the stationary
phase where nutrient is limiting, was exaggerated in pho85
mutants. Thus, the Cdk family of protein kinases might have
an evolutionarily conserved role in regulating cellular levels of
autophagy.
Induction of G1-S cyclins and Cdks as well as evidence of S
phase entry and DNA replication have been well documented
in the neurons AD (Vincent et al., 1997). Abnormal activation of
Cdks, perhaps as a part of aberrant cell-cycle reactivation in
postmitotic neurons, has been proposed to be an important
underlying cause for multiple neurodegenerative disorders
including AD (Herrup and Yang, 2007). On the other hand, activa-
tion of Cdk5 by p25 as a result of calpain-mediated cleavage of
p35 has been implicated in contributing to multiple pathological
features of AD including tau hyperphosphorylation, formation of
neurofibrillary tangles, and neurodegeneration (Cruz et al., 2003).
Autophagy has been demonstrated to play an important
protective role in cellular and animal models of AD and other
neurodegenerative diseases. The ability of Cdk1 and Cdk5 to
phosphorylate Vps34 described here provides a new mecha-
nism by which abnormal activation of Cdks contributes to neuro-
degeneration by negatively regulating autophagy.
EXPERIMENTAL PROCEDURES
Chemicals and Antibodies
The sources of the antibodies used were as follows: monoclonal antibodies
against tubulin and Flag (Sigma), cyclin B1 (sc-245, Santa Cruz Biotech-
nology), HA (HA.11) (Covance), GFP (Clontech), Ub (Dako), Beclin 1 (BD trans-
duction), rabbit polyclonal antibodies against Beclin 1, Cdk5 (C-8), p35 (C-19)
(Santa Cruz Biotechnology), and Vps34 (Zymed). Purified Cdk1/cyclin B and
lPP were from New England Biochemical (Beverly, MA). Alsterpaullon was
from A.G. Scientific (San Diego, CA). Chemicals were obtained from Sigma
unless otherwise noted.
Cell Synchronization
For double thymidine block, HeLa cells were treated with 2 mM thymidine for
16–24 hr and released from G1/S phase in DMEM for 8 hr. HeLa cells were
treated with thymidine again for 16–24 hr, then released from G1/S phase
with DMEM for analyzing mitotic cells.
For serum starvation synchronization, H4 cells were treatedwith DMEMwith
0.5% serum for 3 days. H4 cells were released fromG0 phase with DMEMwith
10% serum and then collected in indicated time.510 Molecular Cell 38, 500–511, May 28, 2010 ª2010 Elsevier Inc.Immunofluorescence
For immunofluorescence analysis, H4 and HeLa cells were grown on cover-
slips. The cells were fixed with 3.7% formaldehyde, permeabilized, and
blocked with 3% bovine serum albumin (BSA). Blocked cells were incubated
with indicated primary antibody overnight at 4C. Cells were then incubated
with Texas red-conjugated anti-rabbit IgG secondary antibody (Jackson
ImmunoResearch) for 1 hr at room temperature. Fluorescence imaging was
done on Nikon Eclipse 80i fluorescent microscope and quantified using
MetaMorph v.7.0 software.
Quantitative Fluorescent Microscopy for Mitosis
H4-LC3-GFP or H4-FYVE-dsRed cells were grown in asynchronous cultures
on glass coverslips, counterstained with Hoechst dye for 1 hr, and fixed for
20 min in 4% paraformaldehyde/PBS. Z series (0.25 mm step size) were
acquired on Nikon inverted TE2000E wide-field microscope using 603
1.4 na oil lens. The images were deconvolved using Autoquant X AutoDeblur.
Quantitation was performed on maximum projection from each Z series using
MetaMorph v7.0 software.
Generation of Anti-Phosphor-Thr159-Vps34 Antibody
In brief, phosphopeptide (DGSEPTR/K(pT)PGRTSST) was synthesized,
purified, and conjugated to KLH by Proteintech Group (Chicago, IL) and
used to immunize two rabbits. Serum was collected from the two rabbits after
four injections.
Vps34 Lipid Kinase Assay
Flag-tagged Vps34-expressed 293T cells were immunoprecipitaed with
anti-Flag M2-agarose affinity gel as immunoprecipitation assay and washed
with NP-40 buffer, eluted with reaction buffer (50 mM Tris-HCl [pH 7.4],
150 mM NaCl) and then preincubated for 10 min at room temperature with
10 mM MnCl2 and 2 mg sonicated phosphatidylinositol (Sigma). Finally we
added 10 mCi [g-32P] ATP and 1 mM cold ATP for 15 min at room temperature.
The kinase reactions were stopped by the addition of 20 ml 8M HCl and
extracted with 160 ml chloroform: methanol (1:1). Extracted phospholipid
products were separated on Silica Gel 60A (Merck). Plates were dried and
exposed by autoradiography to visualize PtdIns3P production.
Mass Spectrometry
The Cdk5 phosphorylation sites were identified using MALDI-TOF MS in the
Taplin Biological Mass Spectrometry Facility (http://gygi.med.harvard.edu/
facility/).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and can be found with this
article online at doi:10.1016/j.molcel.2010.05.009.
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